Leaving the day behind: endovascular therapy beyond 24 h in acute stroke of the anterior and posterior circulation.

Background

There is little evidence of endovascular therapy (EVT) being performed in acute ischemic stroke beyond 24 h, and that evidence is limited to anterior circulation stroke.

Objective

To extend evidence of efficacy and safety of EVT after more than 24 h in both anterior and posterior circulation stroke.

Methods

Local, prospectively collected registries were screened for patients with acute ischemic stroke and large-vessel occlusion who had received either EVT > 24 h after last-seen-well but <24 h after symptom recognition (EVT

Results

Between January 2014 and August 2021,

Conclusion

In selected patients, EVT seems effective and safe beyond 24 h for both anterior and posterior circulation stroke.

Informations de copyright

© The Author(s), 2022.

Déclaration de conflit d'intérêts

Conflict of interest statement: The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: JCP has received consultation fees and travel expenses from Akcea, Bayer, Boehringer Ingelheim, Daiichi Sankyo, and Pfizer. PAR received speaker fees from Bayer, Boehringer Ingelheim, Daiichi Sanyko, and Pfizer. SN reports consulting fees from Brainomix and lecture fees from Boehringer Ingelheim and BMS Pfizer. MM has received consulting honoraria, speaker honoraria, and travel support outside this work from Covidien/Medtronic, MicroVention, and Stryker. The other authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.